KWKathleen P. Wood

Kathleen P. Wood

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Kathleen P. Wood has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Reid C. Chamberlain

    Department of Pediatrics Division of Pediatric Cardiology, Duke University Medical Center Durham North Carolina USA

    2 shared publications
  • Grace S. Lee

    Department of Pediatrics, Duke University Medical Center, Durham, North Carolina

    1 shared publication
  • Greg A. Fleming

    Department of Pediatrics, Duke Pediatric and Congenital Heart Center, Duke University Medical Center, Durham, NC, USA

    1 shared publication
  • Gregory A. Fleming

    Department of Pediatrics Division of Pediatric Cardiology, Duke University Medical Center Durham North Carolina USA

    1 shared publication
  • Heather Van Mater

    Department of Pediatrics, Division of Pediatric Rheumatology, Duke University Medical Center, Durham, North Carolina

    1 shared publication
  • Jennifer S. Li

    Department of Pediatrics, Division of Pediatric Cardiology, Duke University Medical Center, Durham, North Carolina

    1 shared publication

Latest Publications

  • Additive value of invasive haemodynamic assessment for predicting post-operative outcomes after Fontan

    by Kathleen P. Wood, Kristin E. Bonello, Sarah T. Plummer, Reid C. Chamberlain, Greg A. Fleming, Michael G.W. Camitta, Kevin D. Hill

    Routine pre-Fontan cardiac catheterization remains standard practice at most centres. However, with advances in non-invasive risk assessment, an invasive haemodynamic assessment may not be necessary for all patients.Using retrospective data from patients undergoing Fontan palliation at our institution, we developed a multivariable model to predict the likelihood of a composite adverse post-operative outcome including prolonged length of stay ≥ 30 days, hospital readmission within 6 months, and death and/or transplant within 6 months. Our baseline model included non-invasive risk factors obtained from clinical history and echocardiogram. We then incrementally incorporated invasive haemodynamic data to determine if these variables improved risk prediction.Our baseline model correctly predicted favourable versus adverse post-Fontan outcomes in 118/174 (68%) patients. Covariates associated with adverse outcomes included the presence of a systemic right ventricle (adjusted adds ratio [aOR] 2.9; 95% CI 1.4, 5.8; p = 0.004), earlier surgical era (aOR 3.1 for era 1 vs 2; 95% CI 1.5, 6.5; p = 0.002), and performance of concomitant surgical procedures at the time of Fontan surgery (aOR 2.5; 95% CI 1.1, 5.0; p = 0.026). Incremental addition of invasively acquired haemodynamic data did not improve model performance or percentage of outcomes predicted.Invasively acquired haemodynamic data does not add substantially to non-invasive risk stratification in the majority of patients. Pre-Fontan catheterization may still be beneficial for angiographic evaluation of anatomy, for therapeutic intervention, and in select patients with equivocal risk stratification.

  • Open Access

    Coronary Artery Aneurysm Rupture in Kawasaki Disease and SARS-CoV-2 Infection

    by Kathleen P. Wood, Grace S. Lee, Jennifer S. Li, Piers C.A. Barker, Heather Van Mater, Reid C. Chamberlain


  • Update on Transcatheter Device Closure of Congenital Septal Defects

    by Kathleen P. Wood, Gregory A. Fleming, Reid C. Chamberlain

    Purpose of Review The goal of this paper is to review currently available devices for closure of atrial septal defects (ASDs) and ventricular septal defects (VSDs). Recent Findings Favorable results from the ASSURED trial resulted in FDA approval for the most recently developed device for transcatheter ASD closure in the United States. Further studies are required to assist in the development or approval of safe devices for transcatheter perimembranous VSD closure in pediatric patients. Summary Device closure is the less invasive and preferred management option for many ASDs, with multiple studies demonstrating lower complication rates, shorter hospital stays, and lower mortality than surgical repair. Complex ASDs that make device closure more difficult include large defects, rim deficiencies, fenestrated defects, multiple defects, and the presence of pulmonary arterial hypertension. Device closure has also become an accepted alternative to surgery for some types of ventricular septal defects VSDs, though challenges and limitations remain. Future innovations including novel devices and techniques are needed to further expand on the types of defects that can be safely closed via transcatheter approach.